tiprankstipranks
Apellis Pharmaceuticals (APLS)
:APLS

Apellis Pharmaceuticals (APLS) Similar Stocks

Compare
868 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Apellis Pharmaceuticals
$28.35
$3.53B
-57.62%
8 Buy
6 Hold
0 Sell
Moderate Buy
Alnylam Pharma
$251.00
$32.36B
62.21%
15 Buy
3 Hold
0 Sell
Strong Buy
Neurocrine
$116.11
$11.36B
34.72
-11.13%
17 Buy
5 Hold
0 Sell
Strong Buy
Regeneron
$696.02
$74.34B
17.91
-26.86%
16 Buy
3 Hold
1 Sell
Strong Buy
Vertex Pharmaceuticals
$480.33
$118.67B
14.47%
15 Buy
12 Hold
1 Sell
Moderate Buy
Sarepta Therapeutics
$108.41
$10.36B
90.06
-18.05%
13 Buy
1 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
APLS
Apellis Pharmaceuticals
28.35
-38.54
-57.62%
ALNY
Alnylam Pharma
251.00
96.26
62.21%
NBIX
Neurocrine
116.11
-14.54
-11.13%
REGN
Regeneron
696.02
-255.60
-26.86%
VRTX
Vertex Pharmaceuticals
480.33
60.70
14.47%
SRPT
Sarepta Therapeutics
108.41
-23.88
-18.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis